This PT-141 dosage chart keeps two things apart that most dosing pages blur together. One is the dose on the prescribing label, 1.75 mg for premenopausal women with a specific diagnosis. The other is the much wider range of amounts that men and women say they inject from research vials, which no regulator has reviewed. PT-141 is the same molecule as bremelanotide, the active ingredient in Vyleesi, so unlike most peptides it has a real label to check against.
Key Takeaways
- The only approved PT-141 dose is 1.75 mg under the skin, as needed, at least 45 minutes before sex, no more than once per 24 hours and no more than 8 times a month (DailyMed label for Vyleesi, checked 2026-10-11)
- The label covers premenopausal women with acquired, generalized HSDD. It states Vyleesi is not indicated in men or postmenopausal women, so every male dose below is off-label
- Of 50 Reddit comments that named a dose, 31 fell between 0.75 and 1.75 mg and 12 were at 2 mg or higher. Many users described effects arriving hours later than the label's 45 minutes
- The reconstitution math: a 10 mg vial with 2 mL of water is 5 mg/mL, so 1.75 mg is 0.35 mL, or 35 units on a U-100 syringe
- Daily dosing is not a labeled schedule: in one label study 38% of women developed focal skin darkening after 8 consecutive daily doses. This page is information, not medical advice
For the compound itself, the mechanism and the evidence overall, see our PT-141 peptide guide.
PT-141 dosage chart: what the label and published studies used
Start with the table, because it answers the question most people arrive with: which number appears in an official document, and which only appears in forum threads. The short answer is one number on a label, a handful of intranasal numbers from older male studies, and nothing else.
PT-141 doses as written in the label and in published human work
| Dose as published | Route and schedule | Status | |
|---|---|---|---|
| Vyleesi label, 2019 (women) | 1.75 mg | Subcutaneous, abdomen or thigh, as needed, 45+ minutes ahead; 1 dose per 24 hours, 8 per month | FDA-approved for premenopausal women with HSDD |
| RECONNECT phase 3 trials | 1.75 mg | Subcutaneous, as needed, 24 weeks; 1,267 women randomized | Basis of the approval (PMID 31599840) |
| Intranasal study in men, 2004 | Effect at doses above 7 mg | Intranasal spray, single doses; first erections at about 30 minutes | Healthy men and Viagra-responsive ED; investigational (PMID 14963471) |
| Spray plus sildenafil, 2005 | 7.5 mg PT-141 with 25 mg sildenafil | Intranasal, single session, 19 men, crossover | Investigational (PMID 15833522) |
| Sildenafil non-responders, 2008 | 10 mg | Intranasal, 45 minutes to 2 hours before sex, 342 men | Investigational; the paper carries a 2023 expression of concern (PMID 18206919) |
| Men, any approved dose | None | None | Label: not indicated in men or postmenopausal women |
The label dose is not a starting point for a ladder. Vyleesi is a single fixed 1.75 mg dose delivered by a prefilled autoinjector (1.75 mg in 0.3 mL, about 5.8 mg/mL). There is no 1 mg or 1.5 mg strength to step through. The label tells women to inject into the abdomen or thigh at least 45 minutes before anticipated sexual activity, to take no more than one dose in 24 hours, and to avoid more than 8 doses a month. It also says to stop after 8 weeks if there is no improvement, and it admits the duration of effect after each dose is unknown.
Those limits have reasons. In the pooled phase 3 trials nausea was reported by 40% of women on the drug against 1.3% on placebo, flushing by 20.3% and headache by 11.3%. Nausea was highest after the first dose (21%) and fell to about 3% after later doses. Blood pressure rises briefly, by up to about 6 mmHg systolic, peaking two to four hours after the dose, which is why uncontrolled hypertension and known cardiovascular disease are contraindications. Our PT-141 side effects page goes through those in full.
What did 1.75 mg buy? Two placebo-controlled studies randomized 1,267 women for 24 weeks (PMID 31599840). On the label's 1.2 to 6 desire score, women on PT-141 improved by 0.5 and 0.6 points against 0.2 on placebo. Statistically clear and modest; a 2021 re-analysis argued the benefit was small and discontinuation for side effects much higher on the drug (PMID 33678061).
Blood levels rise less than in proportion to dose between 0.3 and 10 mg and plateau around 7.5 mg (about 4.3 times the label dose), and the label says nausea, skin darkening and blood pressure rises are more likely at higher doses. The half-life is about 2.7 hours.
The male literature uses nasal spray. A 2004 double-blind study in healthy men and men with mild to moderate erectile dysfunction found a significant erectile response above 7 mg, with onset around 30 minutes and no maximum tolerated dose identified (PMID 14963471). A 2005 crossover in 19 men paired 7.5 mg nasal PT-141 with a low 25 mg sildenafil dose and found a larger response than sildenafil alone (PMID 15833522). A 2008 trial of 342 sildenafil non-responders used 10 mg, but it carries an expression of concern, so we do not lean on it (PMID 18206919).
No study I could find tested the 0.5 to 2 mg injections that men most often describe, which is the central gap in every online chart.
What Reddit users report taking
To see what people do in practice, I read 368 posts and comments from 17 threads across 11 subreddits, dated 2022 to October 2026. Most were noise: a testosterone thread that mentioned PT-141 once, bot messages, a vendor-run post, a vendor-style cheat sheet and jokes. That left 73 first-hand accounts of using PT-141, from 8 threads in 5 subreddits. Of those, 50 named an amount for themselves; five said they were women and the rest were men or did not say.
That is a small, self-selected sample of people who chose to post, and none of it is verified. Here is how the 50 distribute.
What 50 Reddit accounts said they take, by typical single PT-141 injection
The center of gravity is 0.75 to 1.75 mg per injection, bracketing the label dose, with 1 mg the most commonly named figure (about 11 comments) and 1.5 mg next (about 8). Seven used 0.5 mg or less and 12 used 2 mg or more. One thread asked directly for the highest dose anyone had used, which pulled in 2.5 mg, 3.5 mg, a 3 mg morning built from three injections, and one person who injected 5 mg by accident and had an erection for about 16 hours. Treat those as outliers: feeling fine at 5 mg is not evidence that 5 mg is safe.
Response varies widely, which is the real finding. A diabetic man on a weight-loss drug described very minor effects at 3.5 mg and nothing below it; another said 1.5 mg gave little and 2.25 mg worked. A third went the opposite way (a r/Biohacking commenter, Sep 2026, link): "I found out that Im very sensitive to it. 500mcg was more than enough. Was a painful experience".
Women were a minority. The five who gave a dose reported 0.75 to 2 mg, and three of them described nausea, fatigue or malaise. One on the branded autoinjector (1.75 mg) described a heart rate in the 40s and severe nausea about four hours later. Others said it did little for a partner at 1.75 mg. The sample is far too small to say anything about dose and sex.
Timing is where Reddit disagrees most with the label, which says 45 minutes. Among 15 comments that gave an onset, 4 said about 1 to 2 hours, 3 said 3 to 5 hours, 6 said 6 hours or longer (up to 8 to 12) and 2 gave a wide 2 to 6 hour range. Several said the effect lasted 24 hours or more. The label itself says the optimal window has not been characterized, so no honest chart can settle this.
What went wrong? Of the 73 first-hand accounts, 15 mentioned nausea, 12 flushing, 6 headache, and 6 described fatigue or malaise lasting into the next day or longer. Five said the side effects made it not worth using again, including one who tried four doses and had flu-like symptoms for about 72 hours each time, and a commenter who put it this way (a r/Biohacking commenter, Oct 2026, link): "PT-141 did exactly what it was supposed to. Very, very effective HOWEVER, the side effects were so bad that it negated the positive effects." Ten of 73 reported little or no effect. Five said the effect faded with repeated use, including this account (a r/BodyHackGuide commenter, Aug 2026, link): "for many users The first pin is WOW, but in time it gets sort of not that effective."
At least six comments described erections lasting about 8 to 16 hours. Standard medical advice for any erection treatment is that one lasting more than four hours needs urgent care. One person who injected on four or five days in a row said their face darkened noticeably, which matches the label's skin-darkening warning. One post blamed PT-141 for long-lasting low mood and reduced sexual function through receptor overstimulation; I could not verify that mechanism, so it is a single anecdote.
Reconstitution math: mg, mL and syringe units
PT-141 research vials are usually sold as 10 mg of freeze-dried powder. The label autoinjector needs no math, but a vial does, and dosing errors are common in these threads. In 2026 a vendor-run post told readers that on a U-100 syringe 7 units of a 5 mg/mL mixture equals "approximately 1.75mg". It does not: 7 units is 0.07 mL, which is 0.35 mg. The correct draw for 1.75 mg is 35 units. That is a five-fold error, and the kind of slip that happens when people skip the division.
The formula is units = dose in mg divided by concentration in mg/mL, times 100. A worked example: 10 mg in 2 mL of bacteriostatic water is 5 mg/mL, or 5,000 mcg/mL. A 1 mg dose is 1 divided by 5, or 0.2 mL, which is 20 units on a syringe where 100 units equals 1 mL. Adding more water does not change how much peptide is in the vial, only how much liquid carries each dose.
Syringe units for common PT-141 doses, 10 mg vial (U-100 syringe)
| 0.5 mg | 1 mg | 1.5 mg | 1.75 mg | 2 mg | |
|---|---|---|---|---|---|
| 10 mg + 1 mL (10 mg/mL) | 5 units | 10 units | 15 units | 17.5 units | 20 units |
| 10 mg + 2 mL (5 mg/mL) | 10 units | 20 units | 30 units | 35 units | 40 units |
| 10 mg + 3 mL (3.33 mg/mL) | 15 units | 30 units | 45 units | 52.5 units | 60 units |
| Full doses per 10 mg vial | 20 | 10 | 6 | 5 | 5 |
Vial size scales the same way: a 10 mg vial holds ten 1 mg doses or five full 1.75 mg doses, and a 5 mg vial half as many. Reddit threads also mix up mg and mcg (500 mcg is 0.5 mg), and one user reported 12 units without saying how much water was in the vial, so the dose is unknowable. Write the units out in full.
The vial itself matters. If you want one supplier to check against, Ascension Peptides lists a PT-141 10 mg vial at $49.00 as of 2026-10-11. Kovera Labs tests every batch (HPLC, LC-MS identity, net content, endotoxin, sterility and heavy metals), more than 98% of tested batches pass, and batch certificates are public. Prices are in US dollars, shipping is US only and all sales are final. New customers can use code PEPTIDEDECK for 50% off. This is a research chemical labeled not for human use, not Vyleesi, and nothing about it is approved or prescribed. If you are a premenopausal woman with a diagnosed desire disorder, the legal route is a prescription.
Timing, frequency and how often people repeat it
Frequency is the second thing the label settles and Reddit ignores. In a separate label study, 38% of women developed focal hyperpigmentation after 8 consecutive daily doses, and 14% more developed new changes after 8 more. The label adds that pigment changes may not fully resolve after stopping.
That makes daily "protocols" on dosing sites hard to defend. One site's schedule runs 500 mcg every day for 8 weeks and then steps up; no labeled study supports it, and the label's own evidence points the other way.
Among Reddit users, most describe PT-141 as an occasional tool: once a week, "very rarely", or every few days. One 2023 post suggested waiting about two weeks after 0.5 mg, or three to four weeks after 1 mg, because a repeat after one week felt weak. That is one person's experiment, but fading response appears in five accounts. Nobody has tested it, and "receptor internalization" is a theory, not a result.
For men, the common stack is PT-141 with a PDE5 inhibitor such as sildenafil or tadalafil; at least seven accounts mentioned it. The 2005 study above is the only trial I found, with a deliberately low sildenafil dose. Both classes affect blood pressure, so combining them without a clinician is the riskiest thing in this section.
What changes the dose
These variables are said to matter. Few can be quantified.
Route. The label route is subcutaneous. The male nasal trials needed 7 to 10 mg, several times the injected amount, and vendor nasal products have no verified strength.
Sex and menopause status. The label dose is for premenopausal women only. Users aged 55 to 61 describe good results at 1.5 to 2 mg, but that is off-label, and the label says safety and effectiveness are not established in older patients.
Other medicines. Bremelanotide slows gastric emptying and may reduce absorption of oral drugs that need a threshold level, antibiotics being the label's example. It can substantially reduce exposure to oral naltrexone, so avoid that pair.
Product quality. If a vial holds less than its label says, every number above is wrong. This is the least discussed reason that two people on the same stated dose report different results.
Frequently Asked Questions
What is the PT-141 dosage?
The only approved dose is 1.75 mg injected under the skin, as needed, at least 45 minutes before sex, once per 24 hours at most and no more than 8 times a month, for premenopausal women with HSDD. Everything else, including male use at 0.5 to 2 mg, is off-label and unstudied at those injected amounts.
How many units is 1.75 mg of PT-141?
It depends on the water volume. With a 10 mg vial and 2 mL of water the concentration is 5 mg/mL, so 1.75 mg is 0.35 mL, or 35 units on a U-100 syringe. With 1 mL of water it is 17.5 units and with 3 mL it is 52.5 units.
What dose of PT-141 do men take?
There is no approved male dose. Old nasal spray studies used 7 to 10 mg, and Reddit users who inject most often named 0.75 to 1.75 mg, with a minority at 2 mg or more. The label says Vyleesi is not indicated in men. Talk to a clinician about erectile or desire concerns.
How often can you use PT-141?
The label says no more than one dose in 24 hours and 8 a month, because of blood pressure and skin darkening. After 8 days of daily dosing, 38% of women in one label study had focal hyperpigmentation.
How long does PT-141 take to work?
The label gives a peak blood level at about one hour and says to inject 45 minutes ahead. Of 15 Reddit comments giving a timing, most described several hours, with effects lasting a day or longer. No study has measured this at the doses people inject.
Is PT-141 FDA-approved?
Yes, as Vyleesi, for premenopausal women with acquired, generalized HSDD. Research-grade PT-141 vials sold online are not that product and carry no approval.
Checking a vial before you do any math
The dose math assumes the label is true, so confirm lot, purity and mass first. Ascension Peptides lists the PT-141 10 mg vial at $49.00 as of 2026-10-11, with per-batch Kovera Labs testing and public batch certificates; US shipping only and all sales are final. If you want the prescribed product, ask a clinician about Vyleesi. Related reading: PT-141 for women, PT-141 results and reviews and where to buy PT-141.
Medical Disclaimer: Vyleesi (bremelanotide) is FDA-approved only for premenopausal women with acquired, generalized hypoactive sexual desire disorder. Research-grade PT-141 sold online is not approved, is labeled for laboratory use only, and is not the prescribed product. This article reports label, published and user-reported figures for education. It is not medical advice, a dosing protocol or a recommendation for personal use. Consult a qualified healthcare professional about any health concern, especially if you have high blood pressure or heart disease.







